SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

Zohreh Rahimi, Abbas Parsian
  • Abbas Parsian
    Affiliation not present

Abstract

Hemoglobin S in homozygous state or in combination with one of the structural variants of Hb D-Punjab, Hb O-Arab, Hb C or β-thalassemia mutation results in sickle cell disease (SCD) that is characterized by chronic hemolytic anemia and tissue injury secondary to vasooclusion. A chronic hypercoagulable state in SCD has been established with the increased risk of thromboembolic complications in these patients. The goal of present review is to survey of the literature related to thromboembolic events and genetic risk factors involved in the manifestation of these events in SCD patients with focus on studies from Mediterranean countries. Also, this review covers the pathogenesis of hypercoagulability and alteration in the components of hemostasis system.

Keywords

Sickle cell , Anemia, Thrombosisi, Venous occlusion

Full Text:

PDF
HTML
Submitted: 2014-06-12 16:03:03
Published: 2011-05-23 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
944

Views:
PDF
185
HTML
1548

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Comments on this article

View all comments


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy